Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-08-28, Stock:JNJ, The news for the past five days is as follows:
2019-08-21: NEWS1: Johnson & Johnson (JNJ) Gains But Lags Market: What You Should Know.NEWS2: Opioid Epidemic: Will Pharmas Scramble To Settle As Landmark Case Looms?.NEWS3: Endo Up on Settlement of a Few Cases Related to Opioid Drugs.NEWS4: Endo Up on Settlement of a Few Cases Related to Opioid Drugs.NEWS5: Arrowhead Pharmaceuticals: Buy at the High?.NEWS6: Arrowhead Pharmaceuticals: Buy at the High?.NEWS7: Johnson & Johnson Stock Is a Gamble, but an Interesting One.NEWS8: Johnson & Johnson Stock Is a Gamble, but an Interesting One.NEWS9: Endo Up on Settlement of a Few Cases Related to Opioid Drugs.NEWS10: Arrowhead Pharmaceuticals: Buy at the High?.NEWS11: Oklahoma judge to rule on Monday in opioid lawsuit against J&J.NEWS12: Health Care Sector Update for 08/21/2019: CERC, ALC, ALT, JNJ, PFE, ABT, MRK, AMGN.NEWS13: Health Care Sector Update for 08/21/2019: CERC, ALC, ALT, JNJ, PFE, ABT, MRK, AMGN.NEWS14: Johnson & Johnson Stock Is a Gamble, but an Interesting One.
2019-08-22: NEWS1: Glaxo Submits First Regulatory Application for Daprodustat.NEWS2: Glaxo Submits First Regulatory Application for Daprodustat.NEWS3: Health insurers will expand ACA coverage in 2020.NEWS4: Ex-Dividend Reminder: Johnson & Johnson, Standard and Poors Global and KeyCorp.NEWS5: Ex-Dividend Reminder: Johnson & Johnson, Standard and Poors Global and KeyCorp.NEWS6: Mallinckrodt (MNK) Stock Down 70.8% YTD on Numerous Lawsuits.NEWS7: Mallinckrodt (MNK) Stock Down 70.8% YTD on Numerous Lawsuits.NEWS8: Glaxo Submits First Regulatory Application for Daprodustat.NEWS9: Health Care Sector Update for 08/22/2019: CLSD, RTRX, ADMA, JNJ, PFE, ABT, MRK, AMGN.NEWS10: Health Care Sector Update for 08/22/2019: CLSD, RTRX, ADMA, JNJ, PFE, ABT, MRK, AMGN.NEWS11: Mallinckrodt (MNK) Stock Down 70.8% YTD on Numerous Lawsuits.NEWS12: 3 Days Left Until Johnson & Johnson (NYSE:JNJ) Trades Ex-Dividend.NEWS13: 3 Stocks That Would Be Hurt by a Strong Dollar.NEWS14: Johnson & Johnson (JNJ) Gains But Lags Market: What You Should Know.NEWS15: Johnson & Johnson (JNJ) Gains But Lags Market: What You Should Know.
2019-08-23: NEWS1: Will Lawsuits Sink Johnson & Johnson Stock?.NEWS2: Will Lawsuits Sink Johnson & Johnson Stock?.NEWS3: Will Lawsuits Sink Johnson & Johnson Stock?.NEWS4: Strategic Value Investing: Estimates of Cash Flows.NEWS5: UPDATE 3-Companies file suit in Canada challenging new rules to lower drug prices.NEWS6: Pharma Stock Roundup: ABBV's Rinvoq Gets FDA Nod, BAYRY to Sell Animal Health Unit.NEWS7: Pharma Stock Roundup: ABBV's Rinvoq Gets FDA Nod, BAYRY to Sell Animal Health Unit.NEWS8: J&J's (JNJ) Opioid Lawsuit Verdict in Oklahoma Due Next Week.NEWS9: J&J's (JNJ) Opioid Lawsuit Verdict in Oklahoma Due Next Week.NEWS10: J&J's (JNJ) Opioid Lawsuit Verdict in Oklahoma Due Next Week.NEWS11: Health Care Sector Update for 08/23/2019: ALXN, SEEL, GSK, JNJ, PFE, ABT, MRK, AMGN.NEWS12: Health Care Sector Update for 08/23/2019: ALXN, SEEL, GSK, JNJ, PFE, ABT, MRK, AMGN.NEWS13: Pharma Stock Roundup: ABBV's Rinvoq Gets FDA Nod, BAYRY to Sell Animal Health Unit.NEWS14: Johnson & Johnson (JNJ) Ex-Dividend Date Scheduled for August 26, 2019.NEWS15: Johnson & Johnson (JNJ) Ex-Dividend Date Scheduled for August 26, 2019.
2019-08-26: NEWS1: Judge finds Johnson & Johnson guilty in Oklahoma opioid case, calls for $527 million payment.NEWS2: Johnson & Johnson ordered to pay Oklahoma $572 million for fueling opioid crisis.NEWS3: Judge fines Johnson & Johnson $572 million for role in Oklahoma opioid case.NEWS4: Johnson & Johnson Loses Oklahoma Opioid Case, but the Stock Rises.NEWS5: Factbox: Oklahoma judge finds J&J liable in first trial over opioids.NEWS6: Strategic Value Investing: The Discount Rate.NEWS7: Johnson & Johnson To Appeal Flawed Opioid Judgment in Oklahoma.NEWS8: Pharma Giant J&J Must Pay $572 Million For Oklahoma Opioid Crisis.NEWS9: J&J stock up 4% after judge fines company less than some expected in landmark opioid case.NEWS10: Judge Orders Johnson & Johnson To Pay $572M In Opioid Case.NEWS11: Dow Jones Today: The Return of Trade Optimism.NEWS12: Pharma Giant J&J Must Pay $572 Million For Oklahoman Opioid Crisis.NEWS13: UPDATE 3-Oklahoma judge finds J&J liable in opioid epidemic, orders $572 mln damages.NEWS14: J&J Ordered to Pay $572 Million in Oklahoma Opioid Case.NEWS15: Noteworthy ETF Inflows: IWV, MSFT, AMZN, JNJ.NEWS16: Noteworthy ETF Inflows: IWV, MSFT, AMZN, JNJ.NEWS17: [video]Stocks End Higher After Trump Says China Wants to Make a Deal 'Very Badly'.NEWS18: Oklahoma judge set to rule in the state’s opioid lawsuit.NEWS19: A Big Opioid Decision Is Coming. What to Expect for Johnson & Johnson and Big Pharma..NEWS20: New-look board for drugmaker Boehringer Ingelheim.NEWS21: [video]Stocks Rise After Trump Says China Wants to Make a Deal 'Very Badly'.NEWS22: A Judge in Oklahoma Is Set to Issue a Big Opioid Decision Today. Here’s What to Expect..NEWS23: [video]Johnson & Johnson Sits on Key Support as Opioid Ruling Looms.NEWS24: Health Care Sector Update for 08/26/2019: MDCO, BPTH, CELG, JNJ, PFE, ABT, MRK, AMGN.NEWS25: Health Care Sector Update for 08/26/2019: MDCO, BPTH, CELG, JNJ, PFE, ABT, MRK, AMGN.NEWS26: [video]Johnson & Johnson Faces Oklahoma Opioid Ruling on Monday.NEWS27: Oklahoma judge to rule in $17 billion opioid lawsuit against J&J.NEWS28: J&J liable for $572 million in Oklahoma opioid epidemic trial; shares rise.NEWS29: Johnson & Johnson ordered to pay $572m in opioid trial.
2019-08-27: NEWS1: Johnson & Johnson (JNJ) Gains As Market Dips: What You Should Know.NEWS2: Johnson & Johnson (JNJ) Gains As Market Dips: What You Should Know.NEWS3: Strategic Value Investing: Free Cash Flow Models.NEWS4: Johnson & Johnson (JNJ) Gains As Market Dips: What You Should Know.NEWS5: Here's Why Mallinckrodt Fell Over 17% Today.NEWS6: Here's Why Mallinckrodt Fell Over 17% Today.NEWS7: J&J Opioid Ruling 2019: 13 Things to Know.NEWS8: J&J Opioid Ruling 2019: 13 Things to Know.NEWS9: The S&P 500's Wild August, HubSpot Stock & More - Free Lunch.NEWS10: The S&P 500's Wild August, HubSpot Stock & More - Free Lunch.NEWS11: Stocks End Lower in Choppy Price Action.NEWS12: Stocks End Lower in Choppy Price Action.NEWS13: Market Close Report: NASDAQ Composite index closes at 7,826.95 down -26.79 points.NEWS14: Market Close Report: NASDAQ Composite index closes at 7,826.95 down -26.79 points.NEWS15: UPDATE 6-Purdue Pharma in discussion on $10 bln-$12 bln offer to settle opioid lawsuits -sources.NEWS16: The J&J Opioid Lawsuit Could Let the Real Culprits Off the Hook.NEWS17: Stocks close lower as trade-fight concerns linger, yield-curve inversion deepens.NEWS18: Why The Opioid Verdict Is Actually A 'Devastating Body Blow' For J&J.NEWS19: Dow Jones Today: Not Much Activity, But That’s OK.NEWS20: 5 Top Stock Trades for Wednesday: CMG, SBUX, JNJ.NEWS21: US Stock Market Overview &#8211; Stocks Close Mixed, US Yields Continue to Invert.NEWS22: Stock Market in the Red on Tuesday.NEWS23: The S&P 500's Wild August, HubSpot Stock & More - Free Lunch.NEWS24: Why The Opioid Verdict Is Actually A 'Devastating Body Blow' For J&J.NEWS25: Dow Jones Close To Testing Long-Term Support As Stocks Reverse.NEWS26: Stocks give up gains as investors gauge trade fight, yield curve inversion deepens.NEWS27: Why Johnson & Johnson's Stock Rose After Ordered to Pay $572M Fine In Opioid Outbreak Verdict.NEWS28: Health Care Sector Update for 08/27/2019: JNJ, KERN, SPHS.NEWS29: Health Care Sector Update for 08/27/2019: JNJ, KERN, SPHS.NEWS30: J&J Up Despite $572M Fine in Oklahoma Opioid Abuse Case.NEWS31: J&J Up Despite $572M Fine in Oklahoma Opioid Abuse Case.NEWS32: US STOCKS-Wall Street slips as financials fall, trade hopes flicker.NEWS33: AstraZeneca's Farxiga Gets Fast Track Tag for Renal Outcome.NEWS34: AstraZeneca's Farxiga Gets Fast Track Tag for Renal Outcome.NEWS35: Lilly's (LLY) Taltz Gets FDA Nod for Ankylosing Spondylitis.NEWS36: Lilly's (LLY) Taltz Gets FDA Nod for Ankylosing Spondylitis.NEWS37: Why One Johnson & Johnson Analyst Sees Oklahoma Opioid Ruling As Near-Term Sentiment Positive.NEWS38: J&J to Pay $572M in Opioid Case; Plus Case-Shiller Home Price Read.NEWS39: J&J to Pay $572M in Opioid Case; Plus Case-Shiller Home Price Read.NEWS40: Case-Shiller Index Nudges Up.NEWS41: Case-Shiller Index Nudges Up.NEWS42: Stocks fall as investors gauge trade fight, economic data.NEWS43: J&J Opioid Ruling 2019: 13 Things to Know.NEWS44: The J&J Opioid Verdict Is Just How the U.S. Does Regulation.NEWS45: Johnson & Johnson Ruling Is Seen as a Relief, but 1 Analyst Deems It ‘Very Bearish’.NEWS46: US STOCKS-Wall Street treads water as financials fall, trade hopes flicker.NEWS47: Opioid Crisis: Why Pharma Stocks Aren't Easing On J&J's Light Verdict.NEWS48: How Much Will It Cost Johnson & Johnson To Settle Most of Its Lawsuits?.NEWS49: How Much Will It Cost Johnson & Johnson To Settle Most of Its Lawsuits?.NEWS50: [video]Purdue Pharma Reportedly Offers $10 Billion to $12 Billion for Opioid Settlements.NEWS51: A Look At Benzinga Pro's Most-Searched Tickers For August 27, 2019.NEWS52: Dow Movers: BA, JNJ.NEWS53: Dow Movers: BA, JNJ.NEWS54: Lilly's (LLY) Taltz Gets FDA Nod for Ankylosing Spondylitis.NEWS55: Stocks edge lower as investors gauge trade fight, economic data.NEWS56: AstraZeneca's Farxiga Gets Fast Track Tag for Renal Outcome.NEWS57: 7 Tech Industry Dividend Stocks for Growth and Income.NEWS58: J&J to Pay $572M in Opioid Case; Plus Case-Shiller Home Price Read.NEWS59: Johnson & Johnson Is A Massive Pharma Stock — But Should You Buy It?.NEWS60: J&J Up Despite $572M Fine in Oklahoma Opioid Abuse Case.NEWS61: Johnson & Johnson, Verizon Communications Inc. share gains lead the way, but Dow flat.NEWS62: Case-Shiller Index Nudges Up.NEWS63: US STOCKS-Trade optimism pushes Wall Street higher.NEWS64: Stocks rise for second day as investors gauge trade fight, economic data.NEWS65: These Drug Cos. Could Soon Feel Big Side Effects of Opioid Crisis.NEWS66: Stock Market Rally Continues, As Dow Jones Stocks J&J, Verizon Lead.NEWS67: Opioids stole approximately 250,000 years of life expectancy in Oklahoma.NEWS68: Dow Jones Today: J&J Jumps, Stocks Charge Into China Trade War Lull.NEWS69: Dow Jones Today: J&J Leads Early Advance In China Trade War Lull.NEWS70: Johnson & Johnson, Dow Inc. share gains lead Dow's 100-point climb.NEWS71: Health Care Sector Update for 08/27/2019: NVTR, CTLT, JNJ, PFE, ABT, MRK, AMGN.NEWS72: Health Care Sector Update for 08/27/2019: NVTR, CTLT, JNJ, PFE, ABT, MRK, AMGN.NEWS73: Stocks: Papa John's Soars in Premarket; J&J, Comcast, Zynga All Rise.NEWS74: The Dow Is Rising as Trade Worries Ease, and Johnson & Johnson Weathers Opioid Ruling.NEWS75: Oklahoma Opioid Ruling Gives ‘Green Light’ for Other Lawsuits.NEWS76: Stock futures rise modestly as investors gauge trade fight, economic data.NEWS77: Dow Jones Futures Signal Stock Market Gains Even As Treasury Yield Curve Inverts.NEWS78: Will Johnson & Johnson Become the Next Teva?.NEWS79: The Daily Biotech Pulse: Nuvectra Explores Strategic Options, J&J To Contend Opioid Ruling, Sesen Bio Gets New CFO.NEWS80: Johnson & Johnson calls judge's ruling “flawed,” plans to appeal $572 million ruling in opioid trial.NEWS81: Eye Opener: A landmark ruling against Johnson & Johnson.NEWS82: Stock futures seesaw as investors gauge trade fight, economic data.NEWS83: Johnson & Johnson's Fine May Be the Pin Prick That Keeps Bleeding.NEWS84: [video]Stocks Rise as Investors Remain Optimistic About a U.S.-China Trade Agreement.NEWS85: Dow Jones Futures: The Upside Of A Sideways Stock Market Roiled By China Trade War.NEWS86: J&J liable for $572 million in Oklahoma opioid epidemic trial; shares rise.NEWS87: Johnson & Johnson Rises on $572 Million Fine That's Smaller Than Feared.NEWS88: Johnson & Johnson Is in the News, but How Do the Charts Look?.NEWS89: Johnson & Johnson found guilty in opioid lawsuit in Oklahoma.NEWS90: Dow Futures, Johnson & Johnson, Boeing, Papa John's - 5 Things You Must Know.NEWS91: PRESS DIGEST - Wall Street Journal - Aug. 27.NEWS92: Top 5 Things to Know in the Market on Tuesday.NEWS93: PRESS DIGEST-New York Times business news - Aug 27.NEWS94: Debate over vaccination strategies dogs Ebola efforts in Congo.NEWS95: After Hours: Johnson & Johnson Loses Opioid Case, Amazon Allegedly Loses Top Executive.NEWS96: PRESS DIGEST- Financial Times - Aug. 27.NEWS97: $572M ruling in Oklahoma opioid lawsuit could spell trouble for Triangle pharmas.NEWS98: Johnson and Johnson ordered to pay $572M in opioid case.

Answer: Decrease